Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high-risk Langerhans cell histiocytosis. - Beneforti L; Chinnici A; Coniglio ML; Papa MR; Punzi L; Sieni E; De Fusco C (British journal of haematology, 2024)